Adiponectin in the heart and vascular system.

[1]  P. Scherer,et al.  Adiponectin: mechanistic insights and clinical implications , 2012, Diabetologia.

[2]  A. Xu,et al.  Adiponectin and cardiovascular health: an update , 2012, British journal of pharmacology.

[3]  Yu Jin,et al.  Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype. , 2012, Journal of molecular and cellular cardiology.

[4]  C. Miao,et al.  The role of perivascular adipose tissue in vascular smooth muscle cell growth , 2012, British journal of pharmacology.

[5]  B. Medoff,et al.  Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[6]  S. Miura,et al.  Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina , 2011, Coronary artery disease.

[7]  D. Pimentel,et al.  Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. , 2011, American journal of physiology. Heart and circulatory physiology.

[8]  M. Irwin,et al.  N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats , 2011, PloS one.

[9]  B. Medoff,et al.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension. , 2011, American journal of respiratory cell and molecular biology.

[10]  B. Viollet,et al.  Impaired Expression of Uncoupling Protein 2 Causes Defective Postischemic Angiogenesis in Mice Deficient in AMP-Activated Protein Kinase &agr; Subunits , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. Xu,et al.  Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice. , 2011, Cell metabolism.

[12]  Po-Len Liu,et al.  Associations between Endothelin-1 and Adiponectin in Chronic Heart Failure , 2011, Cardiology.

[13]  Yu Jin,et al.  Adiponectin Induces Vascular Smooth Muscle Cell Differentiation via Repression of Mammalian Target of Rapamycin Complex 1 and FoxO4 , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[14]  W. Pan,et al.  Adiponectin Gene Polymorphism Is Selectively Associated with the Concomitant Presence of Metabolic Syndrome and Essential Hypertension , 2011, PloS one.

[15]  Y. Matsuzawa,et al.  Adiponectin and hypertension. , 2011, American journal of hypertension.

[16]  P. Ruiz-Lozano,et al.  T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.

[17]  M. Birnbaum,et al.  The Pleiotropic Actions of Adiponectin are Initiated via Receptor-Mediated Activation of Ceramidase Activity , 2010, Nature Medicine.

[18]  In-kyu Lee,et al.  Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase. , 2010, The Journal of endocrinology.

[19]  W. Baldwin,et al.  Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors? , 2010, Current opinion in organ transplantation.

[20]  T. Leff,et al.  Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism. , 2010, American journal of physiology. Heart and circulatory physiology.

[21]  D. Ouwens,et al.  The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease , 2010, Journal of cellular and molecular medicine.

[22]  P. Sham,et al.  Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. , 2010, European journal of endocrinology.

[23]  T. Murohara,et al.  Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. , 2010, Journal of molecular and cellular cardiology.

[24]  D. Teupser,et al.  Lack of Association Between Adiponectin Levels and Atherosclerosis in Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Whitehead,et al.  Adiponectin--it's all about the modifications. , 2010, The international journal of biochemistry & cell biology.

[26]  E. Benjamin,et al.  Pericardial Fat Volume Correlates With Inflammatory Markers: The Framingham Heart Study , 2010, Obesity.

[27]  G. Jensen,et al.  Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. , 2010, American journal of hypertension.

[28]  Yajing Wang,et al.  Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury. , 2010, American journal of physiology. Endocrinology and metabolism.

[29]  V. Bordignon,et al.  Adiponectin action from head to toe , 2010, Endocrine.

[30]  E. Wu,et al.  Suppression of Liver Tumor Growth and Metastasis by Adiponectin in Nude Mice through Inhibition of Tumor Angiogenesis and Downregulation of Rho Kinase/IFN-Inducible Protein 10/Matrix Metalloproteinase 9 Signaling , 2010, Clinical Cancer Research.

[31]  T. Murohara,et al.  Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone , 2010, Hypertension.

[32]  S. Kihara,et al.  Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling , 2009, Circulation research.

[33]  Thomas Christen,et al.  Adiponectin Inhibits Allograft Rejection in Murine Cardiac Transplantation , 2009, Transplantation.

[34]  H. Yoshida,et al.  Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome. , 2009, Atherosclerosis.

[35]  M. Kurabayashi,et al.  Effects of ARB or ACE-inhibitor administration on plasma levels of aldosterone and adiponectin in hypertension. , 2009, International heart journal.

[36]  D. Dwyer,et al.  Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[37]  Y. Liu,et al.  Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment. , 2009, American journal of physiology. Endocrinology and metabolism.

[38]  M. Cotrufo,et al.  Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[39]  Chang-an Yu,et al.  Adiponectin protects against cerebral ischemia–reperfusion injury through anti-inflammatory action , 2009, Brain Research.

[40]  J. Pollard,et al.  Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo , 2009, Clinical Cancer Research.

[41]  L. Young,et al.  AMP‐activated protein kinase: a core signalling pathway in the heart , 2009, Acta physiologica.

[42]  P. Scherer,et al.  Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. , 2009, Trends in pharmacological sciences.

[43]  S. Kihara,et al.  Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism , 2009, Molecular and Cellular Biology.

[44]  L. Sade,et al.  Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[45]  P. Libby,et al.  Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. , 2009, American journal of respiratory cell and molecular biology.

[46]  S. Kihara,et al.  Caloric Restriction Stimulates Revascularization in Response to Ischemia via Adiponectin-mediated Activation of Endothelial Nitric-oxide Synthase* , 2009, Journal of Biological Chemistry.

[47]  G. Lip,et al.  Circulating levels of adiponectin, leptin, and tumour necrosis factor α in hypertension , 2009, Annals of medicine.

[48]  Peng Zhang,et al.  Overexpression of Adiponectin Receptors Potentiates the Antiinflammatory Action of Subeffective Dose of Globular Adiponectin in Vascular Endothelial Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[49]  Takamitsu Nakamura,et al.  Low adiponectin levels predict late in-stent restenosis after bare metal stenting in native coronary arteries. , 2008, International journal of cardiology.

[50]  C. Fox,et al.  Common Variants in the Adiponectin Gene (ADIPOQ) Associated With Plasma Adiponectin Levels, Type 2 Diabetes, and Diabetes-Related Quantitative Traits , 2008, Diabetes.

[51]  C. Tanaseanu,et al.  Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase. , 2008, Clinical biochemistry.

[52]  C. Letizia,et al.  Epicardial Adipose Tissue Adiponectin Expression is Related to Intracoronary Adiponectin Levels , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[53]  A. J. Valente,et al.  Adiponectin Blocks Interleukin-18-mediated Endothelial Cell Death via APPL1-dependent AMP-activated Protein Kinase (AMPK) Activation and IKK/NF-κB/PTEN Suppression* , 2008, Journal of Biological Chemistry.

[54]  K. Node,et al.  Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome. , 2008, Metabolism: clinical and experimental.

[55]  Aristea Psilopanagioti,et al.  Expression of Adiponectin and Adiponectin Receptors in Human Pituitary Gland and Brain , 2008, Neuroendocrinology.

[56]  T. Murohara,et al.  Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt , 2008, Journal of hypertension.

[57]  J. Freedman,et al.  Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. , 2008, American journal of physiology. Endocrinology and metabolism.

[58]  C. Morizzo,et al.  Adiponectin and left ventricular structure and function in healthy adults. , 2008, Journal of Clinical Endocrinology and Metabolism.

[59]  Y. Liu,et al.  Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function. , 2008, American journal of physiology. Cell physiology.

[60]  J. Díez,et al.  The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin. , 2008, The Journal of clinical endocrinology and metabolism.

[61]  Natalie J Torok,et al.  Adiponectin Decreases C-Reactive Protein Synthesis and Secretion From Endothelial Cells: Evidence for an Adipose Tissue-Vascular Loop , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[62]  P. Scherer,et al.  Plasma adiponectin complexes have distinct biochemical characteristics. , 2008, Endocrinology.

[63]  B. Goldstein,et al.  Adiponectin Protects Against Angiotensin II or Tumor Necrosis Factor &agr;–Induced Endothelial Cell Monolayer Hyperpermeability: Role of cAMP/PKA Signaling , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[64]  J. Persson,et al.  Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. , 2008, Cardiovascular research.

[65]  R. Cardiff,et al.  T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. , 2008, Cancer research.

[66]  R. Vasan,et al.  Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.

[67]  M. Miyazaki,et al.  Adiponectin Levels Associated with the Development of Hypertension: A Prospective Study , 2008, Hypertension Research.

[68]  P. Libby,et al.  Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis , 2008, Circulation research.

[69]  M. Walker,et al.  Variation in the ADIPOQ gene promoter is associated with carotid intima media thickness independent of plasma adiponectin levels in healthy subjects. , 2008, European heart journal.

[70]  S. Takishita,et al.  Pioglitazone, a Thiazolidinedione Derivative, Attenuates Left Ventricular Hypertrophy and Fibrosis in Salt-Sensitive Hypertension , 2008, Hypertension Research.

[71]  A. Xu,et al.  Post-translational modifications of adiponectin: mechanisms and functional implications. , 2008, The Biochemical journal.

[72]  A. Maisel,et al.  Natriuretic peptides. , 2007, Journal of the American College of Cardiology.

[73]  B. Goldstein,et al.  Adiponectin suppresses IκB kinase activation induced by tumor necrosis factor-α or high glucose in endothelial cells: role of cAMP and AMP kinase signaling , 2007 .

[74]  Qinglin Yang,et al.  Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. , 2007, Journal of molecular and cellular cardiology.

[75]  B. Goldstein,et al.  Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. , 2007, The Journal of clinical investigation.

[76]  S. Kihara,et al.  Adiponectin protects against the development of systolic dysfunction following myocardial infarction. , 2007, Journal of molecular and cellular cardiology.

[77]  H. Yatsuya,et al.  Adiponectin Level and Left Ventricular Hypertrophy in Japanese Men , 2007, Hypertension.

[78]  T. Lam,et al.  Hypoadiponectinemia as a Predictor for the Development of Hypertension: A 5-Year Prospective Study , 2007, Hypertension.

[79]  P. Bora,et al.  Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin , 2007, FEBS letters.

[80]  Takeshi Kimura,et al.  Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[81]  K. Walsh,et al.  Adiponectin actions in the cardiovascular system. , 2007, Cardiovascular research.

[82]  Walter Koch,et al.  Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative Stress , 2007, Circulation.

[83]  L. Risch,et al.  The –11377 C>G promoter variant of the adiponectin gene, prevalence of coronary atherosclerosis, and incidence of vascular events in men , 2007, Thrombosis and Haemostasis.

[84]  M. Kawakami,et al.  Association of Hyperadiponectinemia With Severity of Ventricular Dysfunction in Congestive Heart Failure , 2006 .

[85]  A. Avogaro,et al.  Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high‐risk nondiabetic patients , 2006, Journal of internal medicine.

[86]  H. Fechner,et al.  Abstract 2563: Description of a Local Cardiac Adiponectin System and its Deregulation in Dilated Cardiomyopathy , 2006 .

[87]  J. Higaki,et al.  The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension. , 2006, Clinical therapeutics.

[88]  Kazuo Kimura,et al.  Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. , 2006, Journal of the American College of Cardiology.

[89]  G. Beck,et al.  Adiponectin and mortality in patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[90]  N. Maulik,et al.  Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling. , 2006, Journal of molecular and cellular cardiology.

[91]  Takamitsu Nakamura,et al.  Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. , 2006, American journal of physiology. Heart and circulatory physiology.

[92]  S. Kihara,et al.  Adiponectin Replenishment Ameliorates Obesity-Related Hypertension , 2006, Hypertension.

[93]  J. Manson,et al.  Adiponectin Genetic Variability, Plasma Adiponectin, and Cardiovascular Risk in Patients With Type 2 Diabetes , 2006, Diabetes.

[94]  T. Mikkelsen,et al.  AMP‐dependent protein kinase alpha 2 isoform promotes hypoxia‐induced VEGF expression in human glioblastoma , 2006, Glia.

[95]  Y. Sharabi,et al.  Circulating adiponectin concentrations in patients with congestive heart failure , 2006, Heart.

[96]  M. Adachi,et al.  Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. , 2006, Metabolism: clinical and experimental.

[97]  N. Ruderman,et al.  Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ Agonists* , 2006, Journal of Biological Chemistry.

[98]  F. Kronenberg,et al.  Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. , 2006, Diabetes.

[99]  S. Kihara,et al.  Adiponectin Inhibits Endothelial Synthesis of Interleukin-8 , 2005, Circulation research.

[100]  G. Heigenhauser,et al.  The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. , 2005, Diabetes.

[101]  D. Lawlor,et al.  Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. , 2005, The Journal of clinical endocrinology and metabolism.

[102]  Domenico Corradi,et al.  Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart , 2005, Nature Clinical Practice Cardiovascular Medicine.

[103]  R. Piñeiro,et al.  Adiponectin is synthesized and secreted by human and murine cardiomyocytes , 2005, FEBS letters.

[104]  Jan Frystyk,et al.  Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure , 2005, Circulation.

[105]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[106]  O. Frazier,et al.  Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[107]  T. Funahashi,et al.  Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. , 2005, Cardiovascular research.

[108]  T. Mountokalakis,et al.  Plasma Adiponectin Levels and Five-Year Survival After First-Ever Ischemic Stroke , 2005, Stroke.

[109]  F. Casanueva,et al.  Expression and regulation of adiponectin and receptor in human and rat placenta. , 2005, The Journal of clinical endocrinology and metabolism.

[110]  B. Kemp,et al.  Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. , 2005, The Journal of clinical endocrinology and metabolism.

[111]  E. Rimm,et al.  The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. , 2005, Diabetes.

[112]  L. Yao,et al.  Role of NAD(P)H Oxidase- and Mitochondria-Derived Reactive Oxygen Species in Cardioprotection of Ischemic Reperfusion Injury by Angiotensin II , 2005, Hypertension.

[113]  K. Walsh,et al.  AMP-Activated Protein Kinase Signaling Stimulates VEGF Expression and Angiogenesis in Skeletal Muscle , 2005, Circulation research.

[114]  Shyi-Jang Shin,et al.  Hypoadiponectinemia Is Associated With Ischemic Cerebrovascular Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[115]  Minyoung Lee,et al.  Glucose Deprivation Increases mRNA Stability of Vascular Endothelial Growth Factor through Activation of AMP-activated Protein Kinase in DU145 Prostate Carcinoma* , 2005, Journal of Biological Chemistry.

[116]  David M Maahs,et al.  Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification , 2005, Circulation.

[117]  E. Rimm,et al.  Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.

[118]  Esko Vanninen,et al.  Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic Syndrome , 2004, Circulation.

[119]  S. Brichard,et al.  Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. , 2004, Endocrinology.

[120]  S. Kihara,et al.  Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.

[121]  C. Drevon,et al.  Adiponectin and its receptors are expressed in bone-forming cells. , 2004, Bone.

[122]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis in Response to Tissue Ischemia through Stimulation of AMP-activated Protein Kinase Signaling* , 2004, Journal of Biological Chemistry.

[123]  K. Choi,et al.  Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans , 2004, Clinical endocrinology.

[124]  T. Ogihara,et al.  Hypoadiponectinemia Is an Independent Risk Factor for Hypertension , 2004, Hypertension.

[125]  Y. Shimada,et al.  Implications of plasma concentrations of adiponectin in patients with coronary artery disease , 2004, Heart.

[126]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[127]  T. Ogihara,et al.  Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. , 2004, Journal of the American College of Cardiology.

[128]  S. Kihara,et al.  Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin , 2004, Circulation research.

[129]  S. Kihara,et al.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[130]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[131]  H. Seo,et al.  Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index , 2004, Blood pressure.

[132]  K. Shimamoto,et al.  Role of adiponectin in insulin-resistant hypertension and atherosclerosis. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[133]  K. Walsh,et al.  AMP-activated Protein Kinase (AMPK) Signaling in Endothelial Cells Is Essential for Angiogenesis in Response to Hypoxic Stress* , 2003, Journal of Biological Chemistry.

[134]  T. Funahashi,et al.  Hypoadiponectinemia is closely linked to endothelial dysfunction in man. , 2003, The Journal of clinical endocrinology and metabolism.

[135]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[136]  S. Kihara,et al.  Erratum , 2003, Heart.

[137]  J. Engel,et al.  Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.

[138]  S. Kihara,et al.  Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[139]  M. Lombès,et al.  Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin , 2002, FEBS letters.

[140]  F. Welt,et al.  Inflammation and Restenosis in the Stent Era , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[141]  M. Matsuda,et al.  Role of Adiponectin in Preventing Vascular Stenosis , 2002, The Journal of Biological Chemistry.

[142]  S. Maruoka,et al.  Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. , 2002, European journal of endocrinology.

[143]  M. Matsuda,et al.  Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. , 2002, Diabetes.

[144]  S. Kihara,et al.  Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.

[145]  G. Yoshino,et al.  Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. , 2002, Diabetes care.

[146]  H. Uozumi,et al.  Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Inhibition of Cardiac Hypertrophy In Vitro and In Vivo , 2002 .

[147]  M. Philippova,et al.  Structure and Functions of Classical Cadherins , 2001, Biochemistry (Moscow).

[148]  J. Weber,et al.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[149]  C. Dina,et al.  Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. , 2000, American journal of human genetics.

[150]  NoriyukiOuchi,et al.  Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.

[151]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[152]  T Nakamura,et al.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.

[153]  S. Yeh,et al.  Identification of ARA70 as a Ligand-enhanced Coactivator for the Peroxisome Proliferator-activated Receptor γ* , 1999, The Journal of Biological Chemistry.

[154]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[155]  P. Ortiz de Montellano,et al.  AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.

[156]  G. Barsh,et al.  Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[157]  S. Kudoh,et al.  Activation of p70 S6 protein kinase is necessary for angiotensin II‐induced hypertrophy in neonatal rat cardiac myocytes , 1996, FEBS letters.

[158]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[159]  A. Quyyumi,et al.  Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.

[160]  D. Herrington,et al.  Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. , 1992, Journal of the American College of Cardiology.

[161]  S. King,et al.  Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia , 1989 .

[162]  M. Daskalaki,et al.  Association of resistin and adiponectin with different clinical blood pressure phenotypes , 2011, Journal of Human Hypertension.

[163]  K. Walsh,et al.  Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure. , 2010, Endocrinology.

[164]  T. Leff,et al.  Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. , 2010, American journal of physiology. Endocrinology and metabolism.

[165]  G. Hansmann,et al.  The protective role of adiponectin in pulmonary vascular disease. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[166]  H. Portugal,et al.  Plasma adiponectin in heart transplant recipients , 2009, Clinical transplantation.

[167]  K. Walsh.  Adipokines, myokines and cardiovascular disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[168]  T. Funahashi,et al.  Decreased plasma adiponectin concentration in patients with essential hypertension. , 2003, American journal of hypertension.

[169]  S. Kihara,et al.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[170]  Y. Zou,et al.  Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. , 1997, Circulation research.

[171]  J. Sadoshima,et al.  Expedited Publications Molecular Characterization of Angiotensin Ii- Induced Hypertrophy of Cardiac Myocytes and Hyperplasia of Cardiac Fibroblasts Critical Role of the At1 Receptor Subtype Key Words * Angiotensin Ii * At1 Receptor * Immediate-early Genes * Mitogenesis * Hypertrophy , 2022 .